Macitentan
ATC C02KX04 · 10 markets · 79 records
US 18 records · 1 strengths
- 10 mgtabletOPSUMITOPSYNVI、__no_trade__
AU 18 records · 3 strengths
- 10 mgtabletAPO-MACITENTAN macitentan 10 mg tablet blister packARX-MACITENTAN macitentan 10 mg tablet blister pack、CIP MACITENTAN macitentan 10 mg tablet blister pack、MACITENTAN CIPLA macitentan 10 mg tablet blister pack、MACITENTAN LUPIN macitentan 10 mg tablet blister pack、MACITENTAN-MSN macitentan 10 mg tablet blister pack、MACNIL macitentan 10 mg tablet blister pack、MYTANTEN macitentan 10 mg tablet blister pack、OPONOVA macitentan 10 mg tablet blister pack +4
- 2.5 mgtabletOPSUMIT macitentan 10 mg film coated tablet blister pack
Records without a stated strength · 1 MYTANTEN、OPONOVA、OPSUMIT、OPSYNVI
TW 5 records · 3 strengths
- 10 mgtabletOPSUMITOpsumit®(CM) film-coated tablets 10 mg、傲朴舒膜衣錠10毫克、奧欣明®膜衣錠10毫克
- 2.5 mgtabletOpsumit®(CM) film-coated tablets 10 mg奧欣明可溶錠2.5毫克
Records without a stated strength · 1 OPSYNVI、奧欣威膜衣錠10/20毫克、奧欣威膜衣錠10/40毫克
EU 4 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 MACITENTAN ACCORD、MACITENTAN ACCORDPHARMA、OPSUMIT、YUVANCI
CA 3 records · 2 strengths
SG 3 records · 1 strengths
- 10 mgtabletOPSUMITOPSYNVI
ES 3 records · 1 strengths
- 10 mgtabletOPSUMITYUVANCI
MX 3 records · 2 strengths
- 10 mgtabletKOPTUSAMMABIPUL
Records without a stated strength · 1 OPSYNVI
HK 3 records · 1 strengths
Records without a stated strength · 1 Macitentan、OPSUMIT
GB 2 records · 2 strengths
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|---|
| 10 mg tablet | No trade name OPSUMIT OPSYNVI | OPSUMIT | OPSUMIT OPSYNVI | APO-MACITENTAN macitentan 10 mg tablet blister pack ARX-MACITENTAN macitentan 10 mg tablet blister pack CIP MACITENTAN macitentan 10 mg tablet blister pack+10MACITENTAN CIPLA macitentan 10 mg tablet blister pack MACITENTAN LUPIN macitentan 10 mg tablet blister pack MACITENTAN-MSN macitentan 10 mg tablet blister pack MACNIL macitentan 10 mg tablet blister pack MYTANTEN macitentan 10 mg tablet blister pack OPONOVA macitentan 10 mg tablet blister pack OPSUMIT OPSUMIT macitentan 10 mg film coated tablet blister pack OPSYNVI OPSYNVI 10/40 macitentan 10 mg / tadalafil 40 mg film-coated tablet blister pack | OPSUMIT OPSYNVI | OPSUMIT YUVANCI | KOPTUSAM MABIPUL | OPSUMIT Opsumit®(CM) film-coated tablets 10 mg 傲朴舒膜衣錠10毫克 | ||
| 2.5 mg tablet | OPSUMIT | OPSUMIT | OPSUMIT macitentan 10 mg film coated tablet blister pack | Opsumit®(CM) film-coated tablets 10 mg 奧欣明可溶錠2.5毫克 | ||||||
unknown | MYTANTEN OPONOVA OPSUMIT+1OPSYNVI | Macitentan OPSUMIT | MACITENTAN ACCORD MACITENTAN ACCORDPHARMA OPSUMIT+1YUVANCI | |||||||
tablet | OPSYNVI | OPSYNVI 奧欣威膜衣錠10/20毫克 奧欣威膜衣錠10/40毫克 |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.